Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

David Clemow

7PUBLICATIONS

20CO-AUTHORS

Serious gamesApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Pacific Peoples social, cultural, emotional and spiritual wellbeingMedical mycologyAllergy

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (7)

Sort by Publication Date:

|Apr 16, 2026

Response to: The Long Game in Ulcerative Colitis: Mirikizumab's Four-Year Outcomes.

|Mar 04, 2026

Mirikizumab four-year sustained and durable efficacy and safety in ulcerative colitis: Final findings from the LUCENT-3 open-label extension study.

Bruce E Sands, David B Clemow, Geert D'Haens

|Oct 30, 2024

Patient and Healthcare Professional Satisfaction, Acceptability, and Preference Experiences With Mirikizumab Administration for Ulcerative Colitis: An International Survey.

David Clemow, Christine Radawski, Joe Milata

|Oct 24, 2024

Three-Year Efficacy and Safety of Mirikizumab Following 152 Weeks of Continuous Treatment for Ulcerative Colitis: Results From the LUCENT-3 Open-Label Extension Study.

Bruce E Sands, Geert D'Haens, David B Clemow

|Mar 09, 2024

Two-Year Efficacy and Safety of Mirikizumab Following 104 Weeks of Continuous Treatment for Ulcerative Colitis: Results From the LUCENT-3 Open-Label Extension Study.

Bruce E Sands, Geert D'Haens, David B Clemow

|Feb 13, 2023

Clinical Effect of Mirikizumab Treatment on Bowel Urgency in Patients with Moderately to Severely Active Ulcerative Colitis and the Clinical Relevance of Bowel Urgency Improvement for Disease Remission.

Marla C Dubinsky, David B Clemow, Theresa Hunter Gibble

Pageof 2

Frequent Collaborators

3 joint publications

Severine Vermeire

3 joint publications

Tadakazu Hisamatsu

3 joint publications

Taku Kobayashi

2 joint publications

Joe Milata

2 joint publications

Marla C Dubinsky

2 joint publications

Bruce E Sands

2 joint publications

Remo Panaccione

1 joint publications

Danielle Rodriguez

1 joint publications

Paula Hauck

1 joint publications

Mario F P Peres

Frequent Collaborators

3 joint publications

Severine Vermeire

3 joint publications

Tadakazu Hisamatsu

3 joint publications

Taku Kobayashi

2 joint publications

Joe Milata

Top Related Videos

Multimodal Quantitative Phase Imaging with Digital Holographic Microscopy Accurately Assesses Intestinal Inflammation and Epithelial Wound Healing

Multimodal Quantitative Phase Imaging with Digital Holographic Microscopy Accurately Assesses Intestinal Inflammation and Epithelial Wound Healing

Published on : Sep 13, 2016

Establishment of Coloproctitis Cancer Model in Mice and Evaluation of Therapeutic Effect of Chinese Medicine

Establishment of Coloproctitis Cancer Model in Mice and Evaluation of Therapeutic Effect of Chinese Medicine

Published on : Oct 13, 2023

See more related videos

Top Related Videos

Multimodal Quantitative Phase Imaging with Digital Holographic Microscopy Accurately Assesses Intestinal Inflammation and Epithelial Wound Healing

Multimodal Quantitative Phase Imaging with Digital Holographic Microscopy Accurately Assesses Intestinal Inflammation and Epithelial Wound Healing

Published on : Sep 13, 2016

Establishment of Coloproctitis Cancer Model in Mice and Evaluation of Therapeutic Effect of Chinese Medicine

Establishment of Coloproctitis Cancer Model in Mice and Evaluation of Therapeutic Effect of Chinese Medicine

Published on : Oct 13, 2023

See more related videos